That Marketing Solution Inc (OTCMKTS:TSTS) Given Another Shot
The chart on the right should show you the impressive surge that That Marketing Solution Inc (OTCMKTS:TSTS) experienced back in April. You can also see the series of red candles that the stock drew immediately after it. And if you have just started your research on the company, you’re probably wondering what caused the sudden spike and the violent drop.
It was all due to a paid promotion. Plenty of newsletters received quite a lot of money and they flooded investors’ inboxes with promises of wealth and fortune. The hype did have its effects on the stock and it smashed its way through the $0.40 and $0.50 barriers. Unfortunately, the excitement died down pretty quickly and TSTS suddenly found itself in freefall mode. It eventually found bottom at just under $0.15.
Right now it’s moving north again and unfortunately it’s being fueled by the pumpers for the second time. More than $120 thousand has been spent over the last several days and as a result, we have received more than sixty emails from various promotional newsletters. TSTS is so far reacting pretty well to the pump. The ticker has been experiencing some increased volumes over the last four days and yesterday, after a 19% jump, it stopped at just over $0.31.
So, the stock has already made its promo-induced climb and some people are probably awaiting a drop similar to the one we saw a few months ago. But let’s see if it will really happen.
The truth is, a few events occurred over the last few months, the most significant of which is the launch of TSTS‘ Low T Vitamin. It means that the company should soon be able to log some revenues.
That’s good, but unfortunately, apart from it, not much else has changed since April’s pump. The financial statement at the end of May, for example, looked like this:
- cash: $3,238
- current assets: $74,079
- current liabilities: $622,212
- quarterly net loss: $386,228
Indeed, the Low T Vitamin should liven up things from a financial standpoint, but unfortunately, we can see that not everyone is convinced about its efficacy. What’s more, TSTS made their press release sound as if they have just launched the brand new product on the market. Yet, it’s available on Amazon as well and the only customer review there is almost two years old. The whole thing could make you wonder whether the Low T Vitamin really is as new and as innovative as TSTS present it to be.
And even if it is new and innovative and even if TSTS sell it like hot cakes, the stock might still be threatened by a few investors who got a grand total of 26.8 million shares for $26,800 a couple of years ago. They are the ones who can profit from TSTS regardless of Low T Vitamin’s success.
